CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_35388662_35389058 | Hmx1 | 248 | 0.617417 | -0.49 | 1.7e-04 | Click! |
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_93666253_93666601 | 22.97 |
Gm8580 |
predicted gene 8580 |
581 |
0.67 |
chr11_57986582_57986738 | 9.97 |
Gm12249 |
predicted gene 12249 |
13526 |
0.15 |
chr2_39129919_39130181 | 9.21 |
Scai |
suppressor of cancer cell invasion |
8893 |
0.13 |
chr1_36943704_36943866 | 7.75 |
Tmem131 |
transmembrane protein 131 |
119 |
0.95 |
chr7_120880375_120880588 | 7.45 |
Eef2k |
eukaryotic elongation factor-2 kinase |
4261 |
0.14 |
chr14_120637498_120637681 | 7.40 |
Gm49008 |
predicted gene, 49008 |
4627 |
0.28 |
chr5_114566935_114567994 | 7.38 |
Fam222a |
family with sequence similarity 222, member A |
552 |
0.73 |
chr17_25127091_25127504 | 7.14 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
6094 |
0.1 |
chr2_158175030_158175374 | 7.01 |
1700060C20Rik |
RIKEN cDNA 1700060C20 gene |
16806 |
0.14 |
chr10_100520287_100520558 | 6.99 |
Cep290 |
centrosomal protein 290 |
11696 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 8.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.7 | 8.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 5.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 4.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 4.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 4.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
1.5 | 4.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 4.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.8 | 4.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.3 | 3.9 | GO:1902075 | cellular response to salt(GO:1902075) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.8 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.2 | 7.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 6.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 5.5 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 4.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 4.5 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 4.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.8 | 4.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 3.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 3.6 | GO:0097413 | Lewy body(GO:0097413) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 11.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 9.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 8.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 7.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 5.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 5.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 4.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 4.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 4.6 | GO:0008143 | poly(A) binding(GO:0008143) |
1.5 | 4.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 7.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 7.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 6.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 4.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 3.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 6.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 5.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 5.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 4.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 3.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 3.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |